| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVS | Common Stock | Award | $0 | +136,640 | $0.000000 | 136,640 | 12 Feb 2024 | Direct | F1 | |
| holding | CVS | Common Stock (By Trust) | 431,392 | 12 Feb 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CVS | Stock Appreciation Rights | 192,741 | 12 Feb 2024 | Common Stock | 192,741 | $45.91 | Direct | F2 | |||||
| holding | CVS | Stock Appreciation Rights | 93,989 | 12 Feb 2024 | Common Stock | 93,989 | $37.91 | Direct | F3, F4 | |||||
| holding | CVS | Stock Option | 242,408 | 12 Feb 2024 | Common Stock | 242,408 | $54.19 | Direct | F5 | |||||
| holding | CVS | Stock Option | 211,196 | 12 Feb 2024 | Common Stock | 211,196 | $58.34 | Direct | F6, F7 | |||||
| holding | CVS | Stock Option | 224,604 | 12 Feb 2024 | Common Stock | 224,604 | $74.30 | Direct | F8 | |||||
| holding | CVS | Stock Option | 171,517 | 12 Feb 2024 | Common Stock | 171,517 | $101.09 | Direct | F9 | |||||
| holding | CVS | Stock Option | 244,952 | 12 Feb 2024 | Common Stock | 244,952 | $74.31 | Direct | F10 |
| Id | Content |
|---|---|
| F1 | Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024. |
| F2 | Represents Aetna Inc. Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Incentive Plan (the "Aetna Plan") on February 17, 2017 that were converted into CVS Health SARs in November 2018 pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested in two substantially equal annual installments beginning on February 17, 2019. |
| F3 | Represents SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs in November 2018 pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019. |
| F4 | Represents unvested SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019. |
| F5 | Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| F6 | The number of shares subject to the option were calculated using a 30-day average price. |
| F7 | Option became exercisable in four equal installments, commencing 4/1/2021. |
| F8 | Option became exercisable in four equal installments, commencing 4/1/2022. |
| F9 | Option became exercisable in four equal installments, commencing 4/1/2023. |
| F10 | Option becomes exercisable in four equal annual installments, commencing 4/1/2024. |